How a future IHC Based Companion Diagnostic Reached Clinical Trial Readiness in Six Months In regulated diagnostics, the calendar leaves little room for drift. A sponsor needed an immunohistochemistry (IHC)-based clinical trial assay targeting a transmembrane protein transferred, validated, and submission-ready against an aggressive European timeline.